ESPR vs PCRX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 21, 2026
ESPR
PCRX
Investment Advisor Scores
PCRX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ESPR | PCRX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 4.6382 | 6.25 | ESPR |
| PEG Ratio | -4.78 | 11.2121 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 23.2% | 6.2% | ESPR |
| Earnings Growth | 0.0% | -30.0% | ESPR |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 52.7/100 | 29.9/100 | ESPR |
| Profit Margin | -1.8% | 2.0% | PCRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | EXTENDED | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ESPR
MarkupPrice above SMA50, rising 50-day trend (14.5% over 20 days), RSI 64
PCRX
MarkupPrice above SMA50, rising 50-day trend (8.8% over 20 days), RSI 84
Fundamentals Snapshot
| Metric | ESPR | PCRX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.9 | 10.5 |
| Trailing P/E | 0.0 | 103.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.1% |
| Gross Margin | 0.6% | 0.8% |
| Operating Margin | -0.1% | 0.1% |
| EPS | 0.00 | 0.35 |
| Dividend Yield | — | — |